Vanguard Group Inc Gossamer Bio, Inc. Transaction History

Vanguard Group Inc

$5.37 Trillion
Q1 2025

A detailed history of Vanguard Group Inc transactions in Gossamer Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 10,083,881 shares of GOSS stock, worth $21.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

10,083,881

Previous 10,034,149 0.5%

Holding current value

$21.8 Million

Previous $9.03 Million 22.83%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	BUY	$0.85 - $1.53 $42,272 - $76,089	49,732 Added 0.5%	10,083,881 $11.1 Million
Q4 2024 Feb 11, 2025	SELL	$0.66 - $1.07 $1.14 Million - $1.84 Million	-1,720,248 Reduced 14.63%	10,034,149 $9.03 Million
Q3 2024 Nov 13, 2024	SELL	$0.79 - $1.25 $4,624 - $7,317	-5,854 Reduced 0.05%	11,754,397 $11.6 Million
Q2 2024 Aug 13, 2024	SELL	$0.51 - $1.27 $1,801 - $4,486	-3,533 Reduced 0.03%	11,760,251 $10.6 Million
Q1 2024 May 10, 2024	BUY	$0.8 - $1.51 $102,520 - $193,506	128,150 Added 1.1%	11,763,784 $13.9 Million
Q4 2023 Feb 14, 2024	BUY	$0.48 - $1.08 $176,306 - $396,690	367,306 Added 3.26%	11,635,634 $10.6 Million
Q3 2023 Nov 14, 2023	BUY	$0.78 - $1.82 $6 Million - $14 Million	7,686,213 Added 214.57%	11,268,328 $9.35 Million
Q2 2023 Aug 14, 2023	SELL	$0.98 - $1.53 $2.91 Million - $4.54 Million	-2,967,636 Reduced 45.31%	3,582,115 $4.3 Million
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $1.35 Million - $4.12 Million	-1,410,106 Reduced 17.72%	6,549,751 $8.25 Million
Q4 2022 Feb 10, 2023	BUY	$1.74 - $12.87 $1.07 Million - $7.9 Million	613,694 Added 8.35%	7,959,857 $17.3 Million
Q3 2022 Nov 14, 2022	BUY	$7.21 - $14.88 $10.8 Million - $22.2 Million	1,493,836 Added 25.53%	7,346,163 $88 Million
Q2 2022 Aug 12, 2022	BUY	$5.97 - $9.97 $1.18 Million - $1.97 Million	197,585 Added 3.49%	5,852,327 $49 Million
Q1 2022 May 13, 2022	BUY	$8.44 - $12.49 $567,868 - $840,364	67,283 Added 1.2%	5,654,742 $49.1 Million
Q4 2021 Feb 14, 2022	BUY	$10.12 - $14.07 $897,178 - $1.25 Million	88,654 Added 1.61%	5,587,459 $63.2 Million
Q3 2021 Nov 12, 2021	BUY	$7.25 - $13.23 $476,520 - $869,568	65,727 Added 1.21%	5,498,805 $69.1 Million
Q2 2021 Aug 13, 2021	BUY	$8.0 - $9.75 $43.5 Million - $53 Million	5,433,078 New	5,433,078 $44.1 Million

Others Institutions Holding GOSS

# of Institutions

126

Shares Held

161M

Call Options Held

2.11M

Put Options Held

57.8K

View Full List

About Gossamer Bio, Inc.

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $203M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

More about GOSS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Gossamer Bio, Inc. Transaction History